Abstract
Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Keywords: Connexin, gap junction, carcinogenesis, cancer
Current Signal Transduction Therapy
Title: The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Volume: 2 Issue: 1
Author(s): Kanczuga-koda Luiza, Sulkowski Stanislaw, Koda Mariusz, Wincewicz Andrzej, Rutkowski Tadeusz and Moniuszko Mariola
Affiliation:
Keywords: Connexin, gap junction, carcinogenesis, cancer
Abstract: Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Export Options
About this article
Cite this article as:
Luiza Kanczuga-koda, Stanislaw Sulkowski, Mariusz Koda, Andrzej Wincewicz, Tadeusz Rutkowski and Mariola Moniuszko, The Role of Connexins in Carcinogenesis: Review of Current Knowledge, Current Signal Transduction Therapy 2007; 2 (1) . https://dx.doi.org/10.2174/157436207779317074
DOI https://dx.doi.org/10.2174/157436207779317074 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Current Pharmaceutical Biotechnology Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers
Anti-Cancer Agents in Medicinal Chemistry Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry Cytosine Methyltransferases as Tumor Markers
Current Genomics Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology Smart Biodecorated Hybrid Nanoparticles
Current Bionanotechnology (Discontinued) Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Cancer Therapy Reviews Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Acute Cystitis Caused by Commensal Neisseria oralis: A Case Report and Review of the Literature
Infectious Disorders - Drug Targets Application of NMR Metabolomics to Search for Human Disease Biomarkers
Combinatorial Chemistry & High Throughput Screening Genome-wide Differential-based Analysis of the Relationship between DNA Methylation and Gene Expression in Cancer
Current Bioinformatics Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
Current Medicinal Chemistry Anal Carcinoma
Current Cancer Therapy Reviews The Therapeutic Potential of Targeting Autophagy in the Treatment of Cancer
Current Cancer Drug Targets Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells
Protein & Peptide Letters Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date
Recent Patents on Biomarkers